论文信息 - Erlotinib HCL for glioblastoma multiforme in first relapse, a phase II trial. - 字舞流文

Erlotinib HCL for glioblastoma multiforme in first relapse, a phase II trial.

K. Aldape | M. Prados | P. Mischel | B. Klencke | J. Vredenburgh | T. Cloughesy | A. Yung | S. vanderBurg | D. D. Bigner